Acquiring Semax with COA documentation ensures that laboratory researchers receive a fully verified ACTH(4-10) peptide analog. PX1 Research provides batch-specific Certificates of Analysis for every lot, detailing mass spectrometry identification, RP-HPLC purity exceeding 98%, and endotoxin testing. Every synthesis batch is manufactured in the USA within GMP-compliant facilities to guarantee rigorous analytical standards for preclinical research.
Acquiring Semax with COA documentation ensures that laboratory researchers receive a fully verified ACTH(4-10) peptide analog. PX1 Research provides batch-specific Certificates of Analysis for every lot, detailing mass spectrometry identification, RP-HPLC purity exceeding 98%, and endotoxin testing. Every synthesis batch is manufactured in the USA within GMP-compliant facilities to guarantee rigorous analytical standards for preclinical research.
In modern biochemical research, securing high-purity peptides with verifiable analytical documentation is essential for ensuring experimental reproducibility. Sourcing Semax with COA (Certificate of Analysis) documentation guarantees that investigators can review the precise chemical purity, identity, and bioburden parameters of a specific synthesis lot prior to initiating in vitro or preclinical protocols. Semax—a synthetic heptapeptide derived from the adrenocorticotropic hormone fragment ACTH(4-10) with the sequence Met-Glu-His-Phe-Pro-Gly-Pro—requires precise manufacturing oversight to preserve structural integrity.
When purchasing compounds for cellular assays or quantitative molecular studies, rely on documentation generated through independent, ISO 17025-accredited laboratory testing. A batch-specific COA provides complete transparency regarding sequence identity, molecular weight verification, residual solvents, and purity percentages. Researchers examining Semax research compounds must ensure that analytical profiles match the theoretical mass of 810.9 g/mol, eliminating potential background noise caused by synthesis side-products, truncated sequences, or counter-ion contaminants.
Analyzing a Semax amidate certificate of analysis requires a comprehensive understanding of liquid chromatography and mass spectrometry outputs. The amidated variant incorporates a C-terminal amide modification designed to enhance chemical stability against carboxypeptidase degradation in laboratory environments. Consequently, analytical testing must confirm both sequence identity and the presence of the specific end-cap modification.
A rigorous COA presents dual-spectrum verification: High-Performance Liquid Chromatography (HPLC) chromatograms to quantify optical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) spectra to confirm target molecular weight. On a standardized COA, the main chromatographic peak representing the intact peptide should demonstrate an integrated area under the curve (AUC) corresponding to equal to or greater than 98% purity. Any secondary peaks representing minor deletion sequences or deamidation products are quantified to ensure total impurities remain below strict analytical thresholds.
To maintain rigorous control over experimental variables, research facilities must evaluate suppliers against strict analytical parameters. PX1 Research implements exhaustive verification protocols for every synthesis batch, ensuring uncompromised purity and lot-to-lot consistency. Key criteria for evaluating research-grade peptide documentation include:
• Third-Party COA per Lot: Independent validation from ISO 17025-accredited analytical laboratories verifying chemical composition. • RP-HPLC Purity Analysis: Reverse-phase HPLC profile demonstrating ≥98% purity with quantified peak integrations. • ESI-MS Mass Verification: Mass spectrometry confirming exact molecular mass and sequence alignment. • Endotoxin Assay Validation: Limulus Amebocyte Lysate (LAL) testing ensuring endotoxin levels fall below strict safety thresholds (<0.01 EU/mg). • USA Manufacturing: Synthesis within GMP-compliant facilities located entirely within the United States. • Lot Traceability & Rapid Logistics: Complete chain-of-custody tracking with same-day dispatch (Monday–Friday) from California and Arizona facilities.
Semax is classified structurally as an ACTH(4-10) regulatory peptide analog. Preclinical studies suggest that the compound influences central signaling pathways without demonstrating systemic endocrine activity typically associated with full-length adrenocorticotropic hormone. In vitro assays and animal models indicate that the peptide modulates gene expression associated with brain-derived neurotrophic factor (BDNF) and its primary receptor, tropomyosin receptor kinase B (TrkB).
Investigative models evaluating cellular responses to neurological stress indicate that Semax exposure leads to rapid upregulation of BDNF mRNA transcription in hippocampal and cortical neuronal cultures. Furthermore, preclinical data show that the peptide modulates signaling cascades involving neurotrophin-3 (NT-3) and vascular endothelial growth factor (VEGF). Researchers utilizing our preclinical literature repository can explore how these neurotrophic pathways regulate synaptic plasticity, neuronal survival, and cellular adaptation under ischemic or hypoxic laboratory conditions.
Within the domain of regulatory peptide research, comparative studies frequently evaluate Semax alongside structural analogues and related synthetic regulatory peptides. The primary compounds within this research cluster include Semax, Selank, and N-Acetyl Semax Amidate. Each compound exhibits distinct physicochemical properties, structural modifications, and enzymatic degradation profiles in biological media.
While standard Semax retains the unmodified N-terminal methionine and C-terminal proline sequence, N-Acetyl Semax Amidate features both N-terminal acetylation and C-terminal amidation. These synthetic modifications significantly alter the peptide's hydrophobic profile, resistance to enzymatic cleavage by aminopeptidases, and overall solution stability during extended incubation periods. Conversely, Selank is a heptapeptide derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro), exhibiting distinct receptor interaction profiles focused on GABAergic signaling and cytokine expression rather than direct BDNF gene upregulation.
The integrity of a COA depends entirely on the analytical rigor of the methods employed. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary tool for quantifying chemical purity. Utilizing a C18 stationary phase and an acetonitrile/water gradient with trifluoroacetic acid (TFA) as an ion-pairing reagent, RP-HPLC separates the target peptide from synthesis side-products, deletion sequences, and residual protecting groups. You can learn more about these methodologies in our overview of peptide purity testing methodologies.
Electrospray Ionization Mass Spectrometry (ESI-MS) complements HPLC by confirming the absolute molecular mass of the purified analyte. In ESI-MS analysis, the peptide is ionized into multiply charged species, generating a distinct mass-to-charge (m/z) spectrum. The observed m/z values are calculated to determine the monoisotopic or average molecular weight of the peptide. A valid COA displays both the theoretical mass and the experimentally observed mass, matching within a strict tolerance of ±0.5 Da.
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant threat to cell culture assays and preclinical models. Presence of trace endotoxins in peptide preparations can trigger unspecific inflammatory responses via Toll-like receptor 4 (TLR4) activation, confounding experimental data regarding neurotrophic signaling and cellular stress responses. Research investigating neuroprotection research compounds requires absolute control over baseline bioburden.
PX1 Research subjects every lot of Semax to quantitative Chromogenic Limulus Amebocyte Lysate (LAL) or Recombinant Factor C (rFC) endotoxin testing. By enforcing stringent endotoxin control limits (<0.01 EU/mg), PX1 guarantees that cell viability assays and receptor binding studies reflect the intrinsic activity of the peptide rather than artifacts induced by bacterial contaminants. These endotoxin metrics are explicitly documented on every lot-specific Certificate of Analysis.
To preserve the structural integrity of high-purity Semax, laboratory personnel must follow established handling and reconstitution protocols. Lyophilized peptide powder should be stored upon arrival at -20°C or -80°C in a manual defrost freezer away from ambient light. When prepared for analytical assays, vials should be allowed to equilibrate to room temperature inside a desiccator prior to opening to minimize atmospheric moisture condensation.
Reconstitution should be performed using sterile, laboratory-grade diluents such as bacteriostatic water or sterile 0.9% sodium chloride solution. Gentle swirling is recommended to dissolve the cake; aggressive vortexing or sonic agitation must be avoided to prevent mechanical shear stress and peptide aggregation. Reconstituted stock solutions should be aliquoted into single-use polypropylene tubes and stored at -20°C or lower to avoid repeated freeze-thaw cycles, which can cause peptide degradation over time.
Supply chain reliability and cold-chain integrity are essential factors when procuring high-grade compounds for time-sensitive scientific studies. All peptides available through the PX1 Research catalog are manufactured exclusively in USA-based, GMP-compliant facilities. This domestic manufacturing footprint ensures stringent quality control over every step of solid-phase peptide synthesis (SPPS), purification, and lyophilization.
Every shipment is dispatched directly from specialized distribution hubs in California and Arizona, featuring temperature-controlled packaging materials designed to preserve compound stability during transit. Orders placed before cut-off times receive same-day dispatch Monday through Friday. Institutional laboratories and high-volume research facilities requiring dedicated batch allocations or custom analytical documentation can establish bulk institutional accounts for streamlined procurement and direct technical support.
How do I access a semax with coa for my specific research lot?
PX1 Research provides direct digital access to batch-specific Certificates of Analysis. Each vial is labeled with a unique lot number that corresponds to the analytical documentation available on our portal, detailing RP-HPLC purity charts, ESI-MS spectra, and endotoxin assay results.
What information is detailed on a semax amidate certificate of analysis?
A Semax amidate certificate of analysis includes chemical sequence confirmation, lot identification, theoretical vs. observed molecular weight via ESI-MS, percentage purity determined by RP-HPLC peak integration, counter-ion content, and quantitative LAL endotoxin levels.
Why is RP-HPLC testing necessary for Semax research compounds?
Reverse-Phase High-Performance Liquid Chromatography separates intact Semax from synthesis impurities, truncated peptides, and oxidation products. RP-HPLC peak integration guarantees that the research material achieves target purity levels (≥98%).
What structural differences exist between Semax and N-Acetyl Semax Amidate?
Standard Semax is an unmodified heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro). N-Acetyl Semax Amidate features N-terminal acetylation and C-terminal amidation, modifications designed to increase enzymatic stability against peptidases in laboratory assays.
What are the standard endotoxin limits for PX1 Research peptides?
All PX1 Research compounds undergo quantitative endotoxin testing via LAL or rFC assays, enforcing strict limits below 0.01 EU/mg to prevent unspecific inflammatory signaling in cell culture and preclinical models.
How should lyophilized Semax be stored upon receipt in the laboratory?
Lyophilized Semax vials should be stored long-term at -20°C or -80°C in a dry environment protected from light. Reconstituted solutions should be aliquoted and kept frozen to minimize freeze-thaw degradation.
What diluent is recommended for reconstituting Semax for in vitro research?
Reconstitution is typically performed using laboratory-grade sterile bacteriostatic water, sterile 0.9% normal saline, or appropriate phosphate-buffered saline (PBS), depending on the specific requirements of the planned assay.
Are PX1 Research compounds synthesized in domestic facilities?
Yes. All research compounds offered by PX1 Research are manufactured in the United States within GMP-compliant synthesis facilities and verified by independent ISO 17025-accredited analytical laboratories.
What preclinical pathways are investigated using Semax?
In preclinical research, Semax is evaluated for its influence on neurotrophic factor expression (BDNF, NT-3), TrkB signaling cascades, cellular responses to oxidative stress, and ischemic adaptation in neuronal models.
Can institutional buyers request bulk lots with dedicated COA documentation?
Yes. Institutional accounts and high-volume laboratories can coordinate directly with PX1 Research through our wholesale department to secure single-lot batch allocations with comprehensive analytical validation dossiers.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.